​

Becton, Dickinson and Company (BDX) Stock Forecast, Price Target & Predictions

OverviewRevenueOwnershipFinancialsChartTranscripts

BDX Stock Forecast

Becton, Dickinson and Company (BDX) stock forecast, based on 33 Wall Street analysts, predicts a 12-month average price target of $283.73, with a high of $312.00 and a low of $260.00. This represents a 46.98% increase from the last price of $193.04.

$150 $190 $230 $270 $310 $350 High: $312 Avg: $283.73 Low: $260 Last Closed Price: $193.04

BDX Stock Rating

Becton, Dickinson and Company stock's rating consensus is Buy, based on 33 Wall Street analysts. The breakdown includes 0 Strong Buy (0.00%), 16 Buy (48.48%), 16 Hold (48.48%), 1 Sell (3.03%), and 0 Strong Sell (0.00%).

Buy
Total 33 1 16 16 Strong Sell Sell Hold Buy Strong Buy

BDX Price Target Upside V Benchmarks

TypeNameUpside
StockBecton, Dickinson and Company46.98%
SectorHealthcare Stocks 15.45%
IndustryMedical Instruments & Supplies Stocks23.25%

Price Target Trends

1M3M12M
# Anlaysts--1
Avg Price Target--$260.00
Last Closing Price$193.04$193.04$193.04
Upside/Downside--34.69%
Ratings Trends
DateStrong BuyBuyHoldSellStrong SellTotal
Nov, 252310--15
Oct, 25239--14
Sep, 25238--13
Aug, 25149--14
Jul, 252411--17
Analyst Price Target Forecasts
DateAnalystCompanyPrice TargetPrice when PublishedPrice Target/Price when PublishedPrice Target/Last Closing Price
Apr 23, 2025Jason BednarPiper Sandler$260.00$202.3228.51%34.69%
Oct 01, 2024Vijay KumarEvercore ISI$290.00$241.1020.28%50.23%
Oct 01, 2024Joanna WuenschCitigroup$275.00$241.9313.67%42.46%
Aug 02, 2024Jayson BedfordRaymond James$270.00$239.0912.93%39.87%
Aug 02, 2024Larry BiegelsenWells Fargo$280.00$236.0118.64%45.05%
Jul 02, 2024Becton DickinsonEvercore ISI$285.00$229.2724.31%47.64%
May 30, 2024David RomanGoldman Sachs$274.00$225.0721.74%41.94%
May 06, 2024Matt MiksicBarclays$312.00$234.6832.95%61.62%
Apr 08, 2024David ToungArgus Research$300.00$242.7323.59%55.41%
Jan 06, 2023Morgan Stanley$290.00$258.1212.35%50.23%
Analyst Rating Forecasts
DateCompanyPrevious RatingNew RatingRating Change
Aug 11, 2025Morgan StanleyOverweightOverweighthold
Aug 08, 2025Piper SandlerNeutralNeutralhold
May 22, 2025CitigroupBuyNeutraldowngrade
May 01, 2025William BlairPositiveMarket Performdowngrade
Apr 23, 2025Piper SandlerOverweightOverweighthold
Dec 18, 2024UBSBuyBuyhold
Oct 01, 2024Evercore ISIOutperformOutperformhold
Oct 01, 2024CitigroupNeutralBuyupgrade
Aug 02, 2024Raymond JamesOutperformOutperformhold
Aug 02, 2024Wells FargoOverweightOverweighthold

Financial Forecast

EPS Forecast

$0 $4 $8 $12 $16 $20 Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28
Reported$6.92$5.93$4.97$5.96----
Avg Forecast$12.60$9.91$12.23$13.11$14.39$15.67$16.60$17.76
High Forecast$13.15$11.88$12.34$13.15$14.49$15.91$16.76$17.97
Low Forecast$12.34$7.93$12.15$13.05$14.32$15.47$16.30$17.44
Surprise %-45.08%-40.16%-59.36%-54.54%----

Revenue Forecast

$16B $18B $20B $22B $24B $26B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28
Reported$20.25B$18.87B$19.37B$20.18B----
Avg Forecast$20.02B$19.91B$19.30B$20.17B$21.97B$23.07B$24.20B$25.00B
High Forecast$20.68B$23.89B$19.34B$20.25B$22.06B$23.32B$24.28B$25.23B
Low Forecast$19.70B$15.92B$19.28B$20.10B$21.92B$22.93B$24.11B$24.65B
Surprise %1.16%-5.20%0.36%0.04%----

Net Income Forecast

$1B $2B $3B $4B $5B $6B Sep 21 Sep 22 Sep 23 Sep 24 Sep 25 Sep 26 Sep 27 Sep 28
Sep 21Sep 22Sep 23Sep 24Sep 25Sep 26Sep 27Sep 28
Reported$2.09B$1.78B$1.48B$1.73B----
Avg Forecast$1.49B$1.60B$1.26B$3.81B$4.19B$4.57B$4.81B$5.17B
High Forecast$1.78B$1.92B$1.52B$3.83B$4.22B$4.63B$4.88B$5.23B
Low Forecast$1.19B$1.28B$1.01B$3.80B$4.17B$4.50B$4.74B$5.07B
Surprise %40.74%11.13%17.31%-54.73%----

BDX Forecast FAQ

Is Becton, Dickinson and Company stock a buy?

Becton, Dickinson and Company stock has a consensus rating of Buy, based on 33 Wall Street analysts. The rating breakdown includes 0 Strong Buy, 16 Buy, 16 Hold, 1 Sell, and 0 Strong Sell, reflecting a consensus that Becton, Dickinson and Company is a favorable investment for most analysts.

What is Becton, Dickinson and Company's price target?

Becton, Dickinson and Company's price target, set by 33 Wall Street analysts, averages $283.73 over the next 12 months. The price target range spans from $260 at the low end to $312 at the high end, suggesting a potential 46.98% change from the previous closing price of $193.04.

How does Becton, Dickinson and Company stock forecast compare to its benchmarks?

Becton, Dickinson and Company's stock forecast shows a 46.98% upside, outperforming the average forecast for the healthcare stocks sector (15.45%) and outperforming the medical instruments & supplies stocks industry (23.25%).

What is the breakdown of analyst ratings for Becton, Dickinson and Company over the past three months?

  • November 2025: 13.33% Strong Buy, 20.00% Buy, 66.67% Hold, 0% Sell, 0% Strong Sell.
  • October 2025: 14.29% Strong Buy, 21.43% Buy, 64.29% Hold, 0% Sell, 0% Strong Sell.
  • September 2025: 15.38% Strong Buy, 23.08% Buy, 61.54% Hold, 0% Sell, 0% Strong Sell.

What is Becton, Dickinson and Company’s EPS forecast?

Becton, Dickinson and Company's average annual EPS forecast for its fiscal year ending in September 2025 is $14.39, marking a 141.44% increase from the reported $5.96 in 2024. Estimates for the following years are $15.67 in 2026, $16.6 in 2027, and $17.76 in 2028.

What is Becton, Dickinson and Company’s revenue forecast?

Becton, Dickinson and Company's average annual revenue forecast for its fiscal year ending in September 2025 is $21.97B, reflecting a 8.86% increase from the reported $20.18B in 2024. The forecast for 2026 is $23.07B, followed by $24.2B for 2027, and $25B for 2028.

What is Becton, Dickinson and Company’s net income forecast?

Becton, Dickinson and Company's net income forecast for the fiscal year ending in September 2025 stands at $4.19B, representing an 142.84% increase from the reported $1.73B in 2024. Projections indicate $4.57B in 2026, $4.81B in 2027, and $5.17B in 2028.